Occupational Therapist

Amy Sitabkhan, OTR

2222 Welborn St, Dallas, Texas, 75219-3924

About Amy Sitabkhan

Amy Sitabkhan is a therapist based in Dallas, Texas who is specialized in Occupational Therapy. Active license number of Amy Sitabkhan is 121162 for Occupational Therapy in Texas. Her current practice location is 2222 Welborn St, Dallas. Patients can reach her at 214-559-7790. Amy Sitabkhan is OTR in Occupational Therapy and her NPI number (Unique professional ID assigned by NPPES) is 1134727373.

Amy Sitabkhan provides interventions based on evaluation and which emphasize the therapeutic use of everyday life activities (i.e., occupations) with individuals or groups for the purpose of facilitating participation in roles and situations and in home, school, workplace, community and other settings. Occupational therapy services are provided for the purpose of promoting health and wellness and are provided to those who have or are at risk for developing an illness, injury, disease, disorder, condition, impairment, disability, activity limitation, or participation restriction.

Practice Information

Amy Sitabkhan speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Amy Sitabkhan
Specialization Occupational Therapy
Credentials OTR
Gender Female
Practice Address: 2222 Welborn St,
Dallas, TX - 75219-3924

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1134727373
NPI Enumeration Date: 10 Oct, 2020
NPI Last Update On: 13 Jan, 2023

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Amy Sitabkhan are as mentioned below.

License NumberSpecializationStateStatus
121162Occupational Therapy TexasPrimary

Other Medical Identifiers

Other legacy medical identifiers associated with Amy Sitabkhan such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
121162OtherTexasTEXAS OCCUPATIONAL THERAPIST LICENSE

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Amy Sitabkhan
2222 Welborn St,
Dallas, TX - 75219-3924

Book an Appointment with Amy Sitabkhan

To schedule an appointment, contact Amy Sitabkhan at 2222 Welborn St, Dallas, Texas or call on below stated phone number.

Call to Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Amy Sitabkhan:

Amy Sitabkhan is an occupational therapist specializing in Occupational Therapy. She provides interventions based on evaluation and which emphasize the therapeutic use of everyday life activities (i.e., occupations) with individuals or groups for the purpose of facilitating participation in roles and situations and in home, school, workplace, community and other settings. Occupational therapy services are provided for the purpose of promoting health and wellness and are provided to those who have or are at risk for developing an illness, injury, disease, disorder, condition, impairment, disability, activity limitation, or participation restriction.

Yes, Amy Sitabkhan is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.

Amy Sitabkhan practices at 2222 Welborn St, Dallas, Texas, 75219-3924.

To schedule an appointment with Amy Sitabkhan, please contact the office at 214-559-7790.

Reviews & Feedback

Have you visited Amy Sitabkhan? Share your experience to help others looking for an occupational therapist in Dallas, TX.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.